BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 20563712)

  • 1. Homing in on acute graft vs. host disease: tissue-specific T regulatory and Th17 cells.
    Engelhardt BG; Crowe JE
    Curr Top Microbiol Immunol; 2010; 341():121-46. PubMed ID: 20563712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIF-1α inhibitor echinomycin reduces acute graft-versus-host disease and preserves graft-versus-leukemia effect.
    Yao Y; Wang L; Zhou J; Zhang X
    J Transl Med; 2017 Feb; 15(1):28. PubMed ID: 28183349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue-specific regulatory T cells: biomarker for acute graft-vs-host disease and survival.
    Engelhardt BG; Sengsayadeth SM; Jagasia M; Savani BN; Kassim AA; Lu P; Shyr Y; Yoder SM; Rock MT; Crowe JE
    Exp Hematol; 2012 Dec; 40(12):974-982.e1. PubMed ID: 22885125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-35 mitigates murine acute graft-versus-host disease with retention of graft-versus-leukemia effects.
    Liu Y; Wu Y; Wang Y; Cai Y; Hu B; Bao G; Fang H; Zhao L; Ma S; Cheng Q; Song Y; Liu Y; Zhu Z; Chang H; Yu X; Sun A; Zhang Y; Vignali DA; Wu D; Liu H
    Leukemia; 2015 Apr; 29(4):939-46. PubMed ID: 25363669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caspase-1 inhibition ameliorates murine acute graft versus host disease by modulating the Th1/Th17/Treg balance.
    Chen W; Su G; Xu Y; Guo W; Bhansali R; Pan B; Kong Q; Cheng H; Cao J; Qi K; Zhu F; Li M; Zhu S; Zeng L; Li Z; Wu Q; Xu K
    Int Immunopharmacol; 2021 May; 94():107503. PubMed ID: 33647825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PD-L1 Ameliorates Murine Acute Graft-Versus-Host Disease by Suppressing Effector But Not Regulatory T Cells Function.
    Tang L; Ma S; Gong H; Wang J; Xu Y; Wu D; Sun A
    Arch Immunol Ther Exp (Warsz); 2019 Jun; 67(3):179-187. PubMed ID: 30927016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Galectin-9 alleviates acute graft-versus-host disease after haplo-hematopoietic stem cell transplantation by regulating regulatory T cell/effector T cell imbalance.
    Pang N; Tudahong S; Zhu Y; He J; Han C; Chen G; Wang W; Wang J; Ding J
    Immun Inflamm Dis; 2024 Feb; 12(2):e1177. PubMed ID: 38353382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ADAR1 improved Treg cell function through the miR-21b/Foxp3 axis and inhibits the progression of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Zhao Y; Zheng X; Li M; Zhao J; Wang X; Zhu H
    Int Immunopharmacol; 2023 Feb; 115():109620. PubMed ID: 36577155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-Regulation of alpha4beta7 integrin on peripheral T cell subsets correlates with the development of acute intestinal graft-versus-host disease following allogeneic stem cell transplantation.
    Chen YB; Kim HT; McDonough S; Odze RD; Yao X; Lazo-Kallanian S; Spitzer TR; Soiffer R; Antin JH; Ritz J
    Biol Blood Marrow Transplant; 2009 Sep; 15(9):1066-76. PubMed ID: 19660719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-IL-22 Antibody Attenuates Acute Graft-versus-Host Disease via Increasing Foxp3
    Wu J; Gu J; Zhou S; Lu H; Lu Y; Lu L; Wang X
    J Immunol Res; 2018; 2018():1605341. PubMed ID: 30159338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal Microbiota at Engraftment Influence Acute Graft-Versus-Host Disease
    Han L; Jin H; Zhou L; Zhang X; Fan Z; Dai M; Lin Q; Huang F; Xuan L; Zhang H; Liu Q
    Front Immunol; 2018; 9():669. PubMed ID: 29740427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High expression of heme oxygenase-1 in target organs may attenuate acute graft-versus-host disease through regulation of immune balance of TH17/Treg.
    Yu M; Wang J; Fang Q; Liu P; Chen S; Zhe N; Lin X; Zhang Y; Zhao J; Zhou Z
    Transpl Immunol; 2016 Jul; 37():10-17. PubMed ID: 27168057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ex vivo toll-like receptor 7 tolerance induction in donor lymphocytes prevents murine acute graft-versus-host disease.
    Zogas N; Karponi G; Iordanidis F; Malasidis S; Paraskevas V; Papadopoulou A; Scouras ZG; Anagnostopoulos A; Yannaki E
    Cytotherapy; 2018 Jan; 20(1):149-164. PubMed ID: 29150086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rat acute GvHD is Th1 driven and characterized by predominant donor CD4
    Boieri M; Shah P; Jalapothu D; Zaitseva O; Walter L; Rolstad B; Naper C; Dressel R; Inngjerdingen M
    Exp Hematol; 2017 Jun; 50():33-45.e3. PubMed ID: 28238806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory T cells and IL-17-producing cells in graft-versus-host disease.
    Teshima T; Maeda Y; Ozaki K
    Immunotherapy; 2011 Jul; 3(7):833-52. PubMed ID: 21751953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Quantitative change of Th cell subsets in patients with acute graft-versus-host disease and its clinical significance].
    Wang SH; Da WM; Jin HJ; Jing Y; Su R; Ruan XX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):805-8. PubMed ID: 17708808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Ex Vivo Treatment of Donor T Cells with Cosalane, an HIV Therapeutic and Small-Molecule Antagonist of CC-Chemokine Receptor 7, Separates Acute Graft-versus-Host Disease from Graft-versus-Leukemia Responses in Murine Hematopoietic Stem Cell Transplantation Models.
    Fowler KA; Li K; Whitehurst CB; Bruce DW; Moorman NJ; Aubé J; Coghill JM
    Biol Blood Marrow Transplant; 2019 Jun; 25(6):1062-1074. PubMed ID: 30668984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory T cell expression of CLA or α(4)β(7) and skin or gut acute GVHD outcomes.
    Engelhardt BG; Jagasia M; Savani BN; Bratcher NL; Greer JP; Jiang A; Kassim AA; Lu P; Schuening F; Yoder SM; Rock MT; Crowe JE
    Bone Marrow Transplant; 2011 Mar; 46(3):436-42. PubMed ID: 20577222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of Lkb1 impairs Treg function and stability to aggravate graft-versus-host disease after bone marrow transplantation.
    Su X; Wang Q; Guo W; Pei X; Niu Q; Liu M; Liu Y; Chen S; Feng S; He Y; Yang D; Zhang R; Ma Q; Zhai W; Pang A; Wei J; Huang Y; Luo Y; Han M; Feng X; Jiang E
    Cell Mol Immunol; 2020 May; 17(5):483-495. PubMed ID: 31664223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-22 deficiency in donor T cells attenuates murine acute graft-versus-host disease mortality while sparing the graft-versus-leukemia effect.
    Couturier M; Lamarthée B; Arbez J; Renauld JC; Bossard C; Malard F; Bonnefoy F; Mohty M; Perruche S; Tiberghien P; Saas P; Gaugler B
    Leukemia; 2013 Jul; 27(7):1527-37. PubMed ID: 23399894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.